{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:19:10Z","timestamp":1777580350216,"version":"3.51.4"},"reference-count":37,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Health Sciences University Scientific Research Project","award":["2021\/093"],"award-info":[{"award-number":["2021\/093"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To assess the effect of 0.01% atropine on myopia progression, considering age and sex differences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective study, 51 participants were enrolled in the atropine group and 48 in the control group. One in the atropine group discontinued due to allergic conjunctivitis, leaving 50 for analysis. Participants were aged 6\u201316 years, with a mean age of 11.1\u2009\u00b1\u20092.6 years (atropine) and 10.9\u2009\u00b1\u20092.3 years (control), and had myopia between \u22122.00 and \u22126.00 D. Subjects were categorized by age (6\u20139, 10\u201312, 13\u201316 years) and sex. Spherical equivalent (SE), axial length (AL, via biometry), simulated keratometry (SimK) (via topography), and pupil diameter (via topography) were measured at baseline and at 1, 3, 6, and 12 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Baseline characteristics did not differ significantly between groups (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&gt;\u2009.05). SE progression at 12 months was significantly lower in the atropine group (\u22120.16\u2009\u00b1\u20090.35 D) than in controls (\u22120.31\u2009\u00b1\u20090.35 D;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u2009.041). AL increase was significant at 6 months in the atropine group (0.1\u2009\u00b1\u20090.23 mm,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u2009.003) and at 12 months in both groups (atropine: 0.26\u2009\u00b1\u20090.33 mm,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u2009.001; control: 0.37\u2009\u00b1\u20090.7 mm,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u2009.001). Pupil diameter and SimK changes were more pronounced in the atropine group (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u2009.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Topical 0.01% atropine slows myopia progression, especially in older children. Higher doses may be more effective for younger children and females.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/11206721251377110","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T18:16:13Z","timestamp":1758132973000},"page":"348-362","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of topical 0.01% atropine on myopia progression in Turkish children according to age and sex"],"prefix":"10.1177","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4168-8740","authenticated-orcid":false,"given":"Erdi","family":"Karada\u011f","sequence":"first","affiliation":[{"name":"University of Health Sciences Dr. Lutfi Kirdar Kartal City Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2394-1888","authenticated-orcid":false,"given":"Nesrin Tuta\u015f","family":"G\u00fcnayd\u0131n","sequence":"additional","affiliation":[{"name":"Memorial Bah\u00e7elievler Hospital, Department of Ophthalmology, Arel University, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-018-0139-7"},{"key":"e_1_3_3_3_2","author":"Holden B","year":"2015","unstructured":"Holden B, Mariotti S, Kocur I. THE IMPACT OF MYOPIA AND HIGH MYOPIA. Report of the Joint World Health Organization\u2013Brien Holden Vision Institute Global Scientific Meeting on Myopia. 2015.","journal-title":"THE IMPACT OF MYOPIA AND HIGH MYOPIA. Report of the Joint World Health Organization\u2013Brien Holden Vision Institute Global Scientific Meeting on Myopia"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.01.006"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.12.104034"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2017.0144"},{"key":"e_1_3_3_7_2","first-page":"10","article-title":"Multiple factors causing myopia and the possible treatments: a Mini review","author":"Shinojima A","year":"2022","unstructured":"Shinojima A, Negishi K, Tsubota K, et al. Multiple factors causing myopia and the possible treatments: a Mini review. Front Public Health 2022: 10.","journal-title":"Front Public Health"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.18-25967"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.05.062"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.07.031"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2015.0043"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.05.029"},{"key":"e_1_3_3_13_2","first-page":"1535","article-title":"Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression","volume":"104","author":"Fu A","year":"2020","unstructured":"Fu A, Stapleton F, Wei L, et al. Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression. Br J Ophthalmol 2020; 104: 1535\u20131541.","journal-title":"Br J Ophthalmol"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2019-314819"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.14148"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/aos.15761"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.12.036"},{"key":"e_1_3_3_18_2","first-page":"1657","article-title":"The diluted atropine for inhibition of myopia progression in Korean children","volume":"11","author":"Moon JS","year":"2018","unstructured":"Moon JS, Shin SY. The diluted atropine for inhibition of myopia progression in Korean children. Int J Ophthalmol 2018; 11: 1657\u20131662.","journal-title":"Int J Ophthalmol"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0000000000001378"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0000000000000207"},{"key":"e_1_3_3_21_2","first-page":"182","article-title":"Superdiluted atropine at 0.01% reduces progression in children and adolescents. A 5 year study of safety and effectiveness","volume":"93","author":"Diaz-Llopis M","year":"2018","unstructured":"Diaz-Llopis M, Pinazo-Dur\u00e1n MD. Superdiluted atropine at 0.01% reduces progression in children and adolescents. A 5 year study of safety and effectiveness. Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (Engl Ed) 2018; 93: 182\u2013185.","journal-title":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (Engl Ed)"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000367"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14166"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2017.1091"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0000000000000189"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.10.012"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88719-1"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13603"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0000000000000736"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0b013e3182357f79"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20140258"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-8343"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.05-0888"},{"key":"e_1_3_3_34_2","first-page":"9748576","article-title":"Role of gender in the prevalence of myopia among Polish schoolchildren","volume":"2","author":"Czepita M","year":"2019","unstructured":"Czepita M, Czepita D, Safranow K, et al. Role of gender in the prevalence of myopia among Polish schoolchildren J Ophthalmol 2019; 2: 9748576.","journal-title":"J Ophthalmol"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.151669"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.06.004"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0000000000000037"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241759"}],"container-title":["European Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11206721251377110","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/11206721251377110","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11206721251377110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:41:38Z","timestamp":1777405298000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/11206721251377110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1177\/11206721251377110"],"URL":"https:\/\/doi.org\/10.1177\/11206721251377110","relation":{},"ISSN":["1120-6721","1724-6016"],"issn-type":[{"value":"1120-6721","type":"print"},{"value":"1724-6016","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,17]]}}}